Delivery Order SPE2DX15D3301-DM90
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $131,871.09, is for the provision of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for active duty and retired military personnel and their families. The contract is a firm fixed-price delivery order with no set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,693.00, is for the delivery of a variety of medical products and supplies to support TRICARE, the healthcare program for military personnel, veterans, and their families. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $189,581.40 Firm Fixed Price Delivery Order contract is for the provision of a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for active duty and retired military personnel, their families, and survivors. The contract is not set aside and is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,927.66, is for the provision of various medical supplies and pharmaceuticals to support TRICARE, the healthcare program for active duty and retired military personnel, under a Firm Fixed Price structure. The contract has no set-aside designation, indicating it was an open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,087.43, is for the supply of various pharmaceutical products and medical supplies to support TRICARE, the Defense Department's healthcare program. The contract is a firm fixed-price delivery order with an ultimate completion date of December 22, 2022. It is not designated as a set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,219.00, is for the provision of a variety of medical products and supplies to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The contract is a firm fixed-price arrangement and does not have a set-aside designation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $109,845.57, is for the provision of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The contract has a firm fixed price pricing structure and runs through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $448,560 firm fixed-price contract is for the supply of various medical products and pharmaceuticals to support TRICARE, the healthcare program for active duty and retired military personnel, their families, and survivors. The contract is not designated as a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,615.77 firm fixed-price contract is for the delivery of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for active duty and retired military personnel, their families, and survivors. The contract has no set-aside designation, indicating...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $84,610.19 and is for the delivery of a variety of pharmaceutical products and medical supplies to support TRICARE, the military healthcare program. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC)...
- SPE2DX15D3301Indefinite Delivery Contract
- SPE2DX15D3301-DM90Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $100,445.11, is for the delivery of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for active duty and retired military personnel, their families, and survivors. The contract is a firm fixed-price delivery order that is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.4k | 7/9/16 |